<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is a distinctly rare dramatic condition characterized by widespread <z:mp ids='MP_0005048'>thrombosis</z:mp> of small vessels </plain></SENT>
<SENT sid="1" pm="."><plain>Early diagnosis and aggressive therapies are essential in this condition because of its extremely high mortality rate </plain></SENT>
<SENT sid="2" pm="."><plain>Therapeutic management include heparine, high dose steroids, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, plasma exchange, intravenous immunoglobuline, however a number of patients are refractory to treatment </plain></SENT>
<SENT sid="3" pm="."><plain>AIM: We review and discuss alternative and emerging treatment options by rituximab for patients who fail or cannot tolerate conventional therapy </plain></SENT>
<SENT sid="4" pm="."><plain>CASE-REPORT: A 36-year-old female with a two mounths history of <z:hpo ids='HP_0002094'>dyspnea</z:hpo>, palpitation and <z:hpo ids='HP_0100749'>chest pain</z:hpo> was admitted </plain></SENT>
<SENT sid="5" pm="."><plain>Physical examination upon admission revealed a <z:hpo ids='HP_0001945'>fever</z:hpo>, ischemic digital <z:mp ids='MP_0001651'>necrosis</z:mp>, <z:hpo ids='HP_0100324'>scleroderma</z:hpo> of the hands and beaking of the nose </plain></SENT>
<SENT sid="6" pm="."><plain>Laboratory tests showed <z:mpath ids='MPATH_458'>normal</z:mpath> level of liver enzymes, elevation of <z:chebi fb="0" ids="16737">creatinine</z:chebi> level, <z:hpo ids='HP_0001888'>lymphopenia</z:hpo>, <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo> with negative Coombs tests, <z:hpo ids='HP_0001873'>low platelet count</z:hpo>, <z:hpo ids='HP_0003645'>prolonged partial thromboplastin time</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The D-Dimer value was 158 ng/ml </plain></SENT>
<SENT sid="8" pm="."><plain>Urinalysis revealed a <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Antinuclear antibody tests and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> were strongly positive </plain></SENT>
<SENT sid="10" pm="."><plain>Echocardiography revealed severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> and <z:hpo ids='HP_0001701'>pericarditis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>There was no <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> on thoracic angio tomodensitometry </plain></SENT>
<SENT sid="12" pm="."><plain>The diagnosis of catastrophic <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome associated with systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and <z:hpo ids='HP_0100324'>scleroderma</z:hpo> was established </plain></SENT>
<SENT sid="13" pm="."><plain>She was treated with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, corticotherapy, one pulse of intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, 2 doses of intravenous immunoglobuline and 5 sessions of plasmapheresis </plain></SENT>
<SENT sid="14" pm="."><plain>Because of lack of response 2 doses of 375 mg weekly rituximab i.v. were added but she developed <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, alveolar haemorrhage and she died </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSION: Effectiveness of Rituximab for the CSAPL should be demonstrated by further studies </plain></SENT>
</text></document>